Photo by Anthony Behar/Sipa USA)(Sipa via AP Images

Covid-19 roundup: FDA au­tho­rizes Pfiz­er-BioN­Tech boost­er for 12-to-15-year-olds; Ear­ly re­sults sug­gest an­tivi­rals may hold up against Omi­cron

Chil­dren be­tween the ages of 12 and 15 years old are now el­i­gi­ble for a third dose of the Pfiz­er-BioN­Tech vac­cine af­ter the FDA au­tho­rized it Mon­day, as well as a third shot for those be­tween 5 and 11 who are im­muno­com­pro­mised.

The FDA al­so short­ened the time be­tween the com­ple­tion of a pri­ma­ry vac­cine and a boost­er shot to five months for Pfiz­er’s jab, al­though Mod­er­na’s boost­er in­ter­val re­mains at 6 months. The moves come as Omi­cron has ripped through the US, caus­ing the num­ber of pos­i­tive cas­es to sky­rock­et.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.